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Abstract
Peyer’s patches (PP) are an important component in the immune response against intestinal pathogens. Two independent,
spontaneous mutations in the mouse Sharpin gene (Sharpincpdm and Sharpincpdm-Dem) result in the absence of PP and
disrupted splenic white pulp in adult mice, although a full complement of lymph nodes is present. Here we report that
rudimentary PP begin to develop in Sharpincpdm mice during embryogenesis, but lack the organizational patterns that are
typical of this tissue. In the present study, small intestines examined at weekly intervals from birth to maturity showed
spontaneous regression of PP in mutant mice with concurrent infiltration of granulocytes. At 5 to 6 weeks of age, only
indistinct remnants of granulocytic accumulations remain. Transplantation of normal bone marrow into Sharpincpdm mice at
7 days of age did not prevent regression of PP in bone marrow chimeras examined at 7 to 8 weeks of age. These findings
indicate that SHARPIN expression is required for the normal development and maintenance, but not initiation, of PP.
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Introduction
Peyer’s patches (PP) are organized secondary lymphoid tissues
located in the anti-mesenteric wall of the small intestine of
mammals. They comprise the major inductive sites for adaptive
immune responses to intestinal antigens. PP are an important
source of IgA-producing B cells that develop through class
switching from IgM+ cells under the influence of T cells in the
germinal centers of PP, although T cell–independent IgA
production also occurs [1].
PP development (reviewed in [2]) is a nuclear factor kappa B
(NFKB)-dependent process initiated in the intestinal stroma of
embryonic mice by vascular cell adhesion molecule 1 (VCAM1)+,
intracellular adhesion molecule 1 (ICAM1)+ stromal organizer
cells on the antimesenteric surface of the small intestine at 15.5
days post conception (dpc), followed by recruitment of lymphoid
tissue inducer (LTi) cells. LTi cells express multiple surface
markers, including CD4, PTPRC (CD45R or B220), IL7R, and
CXCR5 (BLR1). Interactions between IL7R signal-induced
lymphotoxin (LT) alpha1beta2 expression on LTi cells and the
LT beta receptor (LTBR) on organizer cells activate NFKB
transcription factors, driving chemokine expression to create the
microenvironment for further PP development. Compartmental-
ization of PP anlagen into biologically efficient structures is
initiated near the end of gestation in mice, prior to the entry of
lymphocytes. Recruitment of mature B and T cells begins after
18.5 days post conception (dpc), and segregation of B and T cell
compartments is completed postpartum [3].
C57BL/KaLawRij-Sharpincpdm/RijSunJ mutant mice have se-
vere, progressive multiorgan inflammation [4]. PP are absent in
adult (examined at 6+ weeks of age) Sharpincpdm mice, as determined
by serial sections of Swiss rolls of the small intestine, and
accordingly fecal IgA levels are greatly reduced [5]. The spleen
has decreased white pulp, lacks a defined marginal zone, and B cell
function is impaired, with significantly reduced serum IgG, IgA,
and IgE. Although all lymph nodes are present, the remaining
secondary immune organs lack follicular dendritic cells (FDCs), B
cell follicles, and germinal centers [5,6].
To begin to elucidate the mechanism underlying the absence of
PP in adult Sharpincpdm mutant mice, the small intestines of neonatal
and young mice homozygous for the recessive Sharpincpdm mutation
were examined for evidence of PP anlagen. Surprisingly, PP
populated by B and T lymphocytes were present in neonatal
Sharpincpdm mice, although they were smaller in size and lacked the
organization seen in PP of mice heterozygous or wildtype for
Sharpin (controls). Spontaneous regression of PP in maturing
Sharpincpdm mice was typically associated with infiltration by
granulocytes.
Results
Clusters of ICAM1+ cells were observed by whole mount
immunohistochemistry (WMI) in the small intestines of neonatal
(0–1 day postpartum) mutant and control mice. There was no
significant difference in the number of these patches (mean, 4.7
and 5.6 in mutants and controls, respectively), although increased
labeling intensity and compartmentalization of these cells could be
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readily observed in PP of control, but not mutant, mice (Fig. 1A,
B).
B220-positive foci were readily identified at the anti-mesenteric
surface of the small intestines of neonatal mice by WMI. At 1 to 2
weeks of age, multiple individual follicles could be discerned in the
PP of control mice. The size of follicles and of individual PP
subjectively increased with age in control mice. Representative
findings are shown in Fig. 1C. B220-positive foci were also
present in the intestine of mutant mice between 0 days and 5
weeks of age, however, these did not contain apparent follicular
structures. They were less organized, smaller, and less prominent
than those of the controls, and the intensity of the labeling became
variable and overall decreased greatly by 3 weeks of age. Although
organized PP could easily be identified and B220+ staining was still
present in control PP up to 6 weeks of age this method became less
reliable (with less uniform staining) in older mice.
Sections of the small intestine were evaluated by microscopic
examination of hematoxylin and eosin (H&E) stained Swiss rolls of
the small intestine, confirming the presence of PP in young mutant
and control mice. These patches did not have defined follicles in
mutant mice, in contrast to controls. In some PP of mutant mice at
2 to 3 weeks of age, there were increased numbers of non-
lymphoid cells, including granulocytes, stromal cells, and macro-
phages. Non-lymphoid cells comprised a small fraction of the cells
in PP of the controls. At 4 and 5 weeks of age, a dramatic change
was seen in the size and cell population of the few remaining
patches in Sharpincpdm mice, in that they were composed of sparse
numbers of lymphocytes admixed with granulocytes, macrophag-
es, and increased amounts of fibrous connective tissue (Fig. 2). In
mutant mice aged 6 weeks and older, no distinct PP were seen
using this method. However, occasional remnants of granulocytic
accumulations were observed in the antimesenteric submucosa of
the small intestine, presumably the sites of degenerate PP.
To determine the composition and organization of PP remnants
in young mutant mice, frozen sections of the intestine were
examined using indirect immunofluorescence (IFA) microscopy
with antibodies against CD45RB and CD3 for B and T cells,
respectively. Similar to results obtained via other methods, PP of
mutant mice appeared smaller than the PP of controls at all time
points, and fewer PP were typically found. In addition, mutant PP
remnants were consistently less organized, with little compart-
mentalization of B and T cells and no follicular structures
Figure 1. Lack of compartmentalized Peyer’s patches (PP) in Sharpincpdm mutant mice. (A) Intercellular adhesion molecule (ICAM1) labeling
in the small intestine of 1 day old mice. Numerous ICAM1+ patches are present in the Sharpincpdm mutant mice (left), however they lack the distinct
compartmentalization seen in most ICAM1+ patches of control (+/?) mice (right). (B) Mean ICAM1+ counts for a litter of 1 day old Sharpincpdm mutant
(N = 3) and control (+/?) mice (N= 8). Bars indicate standard error of the mean. (C) Anti-CD45RB (B220) labeling in the small intestine of mutant
Sharpincpdm (top panel) and control (bottom panel) mice at (left) 4 days, (center) 1 week, and (right) 2 weeks of age. Images are representative of 3 to
4 mice per group; PP of control mice appear compartmentalized and follicular structures are evident, and overall size of PP subjectively increase with
age, while those of mutant mice do not show these features. WMI.
doi:10.1371/journal.pone.0055224.g001
PP in Sharpin Deficient Mice
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observed. As mice matured, increasing numbers of non-B, non-T
cells were observed in the PP remnants of mutant mice, consistent
with the infiltration of granulocytic populations observed by H&E
staining. By contrast, the PP of control mice subjectively increased
in size with age, and exhibited distinct compartments, with CD3+
T cells mostly concentrated in the interfollicular areas and
occasionally seen in B cell follicles (Fig. 3).
The splenic white pulp of adult Sharpincpdm mutant mice is
disorganized with poor separation of B and T cell areas [5]. To
determine whether the observed changes in the PP of mutant mice
parallel changes in the organization of white pulp, frozen sections
of the spleen were examined in mutant and control mice at weekly
intervals up to 5 weeks of age, identifying cell populations as
described for the intestine. While differences were subtle in mice
,2 weeks of age, the white pulp in mutant mice appeared smaller
and more dispersed than that of controls at all time points. White
pulp size and organization subjectively increased in the spleens of
control mice as they matured. At 4 and 5 weeks of age, the white
pulp of Sharpincpdm mutant mice became progressively more
disorganized with increased mixing of B and T cell populations
and scattering of B cells along with increased numbers of non-
lymphoid cells. Splenomegaly caused by increased extramedullary
hematopoiesis was common in mutant mice. In control mice,
segregation of the red and white pulp was more distinct, and the
white pulp contained numerous lymphocytes. Representative
images are shown in Fig. 4.
To further evaluate whether loss of PP may be attributable to
defects in hematopoietic cells, stromal cells, or both, bone marrow
cells from healthy histocompatible donor mice transgenically
expressing green fluorescent protein (GFP)+ were transferred into
irradiated Sharpincpdm and control mice at 7 days of age. Recipient
mice (6 mutants and 8 controls of both sexes) were euthanized and
necropsied at 7 to 8 weeks of age. Engraftment of donor cells was
confirmed by immunohistochemistry for GFP+ cells [7] in the
spleen, liver, colon, and cecum. Although the skin phenotype of
mutant mice was subjectively milder than expected (ie, mild to
moderate rather than moderate to severe) in most recipents, no
evidence of reconstitution of PP was detected histologically (by
examination of Swiss rolls of the intestine as described) in any of
the recipient mutant mice. Normal PPs were found in recipient
control mice histologically, and repopulation of lymphoid tissues
including the gut associated lymphoid tissues of the large intestine
Figure 2. Regression of lymphoid tissue in Sharpincpdm mutant mice. Histologic sections of Peyer’s patches in control mice (A) and residual
lymphoid tissue in Sharpincpdm mutant mice (B) at 1 to 5 weeks of age are shown. Images represent at least 3 mice per group examined at each time
point. Some variability is observed in the cellular composition of individual lymphoid tissue remnants in mutant mice, however eosinophilic/
granulocytic and stromal effacement is common. Lymphoid patches were not found in some mutant mice at 4 to 5 weeks using this method. H&E.
doi:10.1371/journal.pone.0055224.g002
PP in Sharpin Deficient Mice
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Figure 3. B220+ B and CD3+ T lymphocyte organization in Peyer’s patches (10X). Images represent at least 3 control mice (A) and
Sharpincpdm mutant mice (B) examined at each time point. Lymphoid patches were not found in the small intestines of some 4- and 5-week old
Sharpincpdm mutant mice using this method. (C) Longitudinal section of a Peyer’s patch from a control mouse showing normal segregation of B and T
cell zones. Green–B220+ B cells, Red–CD3+ T cells, Blue–DAPI (nuclear) counterstain. IFA.
doi:10.1371/journal.pone.0055224.g003
Figure 4. Comparison of splenic white pulp in Sharpincpdm mutant and control mice. The white pulp of control (A) mice is discrete and well-
organized. B and T cell regions of the Sharpincpdm mutant (B) spleen are smaller, organization is poor, and splenomegaly is common (106). Images
represent at least 3 mice per group examined at each time point. Green–B220+ B cells, Red–CD3+ T cells, Blue–DAPI (nuclear) counterstain. IFA.
doi:10.1371/journal.pone.0055224.g004
PP in Sharpin Deficient Mice
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and cecum by donor cells was subsequently confirmed by
immunohistochemistry for GFP+ cells.
Discussion
The development of PP during late embryogenesis has been well
characterized in recent years. This varies from development of
other secondary lymphoid organs in some key ways. In lymph
node organogenesis, early lymph sacs bud from vascular endo-
thelium in a prospero-related homeobox 1 (PROX1)-dependent
manner to accumulate LTi cells, while PP are initiated by the Ret
proto-oncogene-dependent clustering of previously scattered LTi
cells with KIT+, ITGAX (CD11C)+ initiator cells in the small
intestine [8,9]. The local microenvironments for these tissues
require different cytokines and signaling pathways to induce
lymphoid development. Whereas PP require JAK3-dependent
IL7R signaling, lymph nodes require TRAF6-dependent
TNFSF11 (TRANCE) signaling for the differentiation and
function of LTi cells [10–12]. Additionally, the signaling
requirements for cervical and mesenteric lymph nodes can vary
from those of other lymph nodes (reviewed in [13]). Development
of splenic white pulp is not dependent on LTi cells, but its
organization and maturation requires activation of NFKB through
LTA1B2 signaling in lymphocytes [14]. Similarly, although
pathways involving TNF, TNFRSF1A, LTA, LTB, TNFSF14
(LIGHT), and the LTBR all have complex roles in the
development and organization of secondary lymphoid organs
[15–21], LTA1B2 activation of NFKB transcription factors via the
LTBR is indispensible for lymph node and PP development. The
LTBR is one of several tumor necrosis factor (TNF) superfamily
receptors, the binding of which lead to activation of inhibitor of
kappa B kinases (IKKs) and MAP3K14 (NFKB inducing kinase
[NIK]); these phosphorylate inhibitory proteins that sequester
NFKB homo- and heterodimers in the cytoplasm, and subsequent
ubiquitin-proteasome pathway degradation of the inhibitors allows
nuclear translocation of NFKB complexes for transcription of
target genes (reviewed in [22]). Among genes downstream of the
LTBR and other TNF superfamily receptors are those involved in
inflammation, cell survival, and innate immunity (primarily
through canonical activation of the NFKB1-P50 heterodimer),
lymphoid tissue development (primarily through noncanonical
activation of the NFKB2-P52 heterodimer), and organization of
these structures (involving both pathways).
PP are absent in mice lacking Lta, Ltb [17,18], Ltbr [21],
Map3k14 [23], Il7r, Jak3 [10], Rorc [24], Id2 [25], Ikzf1 (Ikaros) [26],
Relb, Nfkb2 [27], or the Ret proto-oncogene [9]. Significant
blunting of PP development is seen in mice lacking Cxcl13 [28]
or its receptor Cxcr5 [29] and in some mice lacking Tnf [30,31] or
Tnfrsf1a [32]. It is interesting to note that in all of these mice, with
the exception of those with defects in the IL7 receptor pathway,
lymph node genesis is also affected. In contrast, adult Sharpincpdm
mutant mice have a full complement of lymph nodes, although
these are often infiltrated by granulocytes, whereas they lack PP
[5].
SHARPIN was recently discovered to be component of the
RBCK1 (HOIL1L) and RNF31 (HOIP)-containing linear ubiqui-
tin chain assembly complex. Linear ubiquitination of the IKK
regulatory subunit IKBKG (NEMO) is among the functions of this
complex, and SHARPIN deficiency was shown to result in
impaired CD40- and TNFA-induced activation of the IKK
complex and subsequent canonical NFKB activation in B cells and
mouse embryo fibroblasts in vitro [33–35]. Although activation of
the noncanonical NFKB pathway, which is essential for secondary
lymphoid organ development, was not reported to be affected in B
cells or mouse embryo fibroblasts, SHARPIN may potentially
influence this pathway in other cell types or in specialized
microenvironments during lymphoid tissue development. Investi-
gators demonstrated that ablation of TNF in Sharpincpdm mutant
mice rescued the inflammatory skin phenotype and eliminated
granulocyte accumulations in various organs, but did not rescue
development of the splenic marginal zone or PP [33]. Thus, the
inflammatory cell infiltrates observed in regressing PP of young
mice in the present study are not likely to be the cause of PP loss.
Dysregulation of local chemokine expression in high endothelial
venules and stromal tissues may contribute to the accumulation of
granulocytes in secondary lymphoid organs in this disease.
Findings of the present study demonstrate that while PP
development is initiated in Sharpincpdm mutant mice, essential
compartmentalization which normally begins prior to the entry of
lymphocytes fails. Efficient segregation into B and T cells areas is
lacking, and the previously described absence of FDCs, possibly a
consequence of the faulty B cell maturation or defects in stromal
FDC precursors, leads to absence of B cell follicles [36,37].
Changes in the spleen, although less severe, parallel those observed
in the PPs. Increased extramedullary myelopoiesis accompanies
accumulation of granulocytes in the spleens of mutant mice over
time. Whereas organization, compartmentalization, and lympho-
cyte accumulations increase with maturity in spleens of controls, a
more primitive white pulp structure is evident in mutant mice,
with increased mixing of B and T cells beginning between 2 and 4
weeks of age, and failure of these compartments to expand.
Cooperative signaling between stromal tissues and hematopoe-
tic cells regulates cell survival, differentiation, and proliferation, as
well as the segregation and trafficking of B and T lymphocytes in
secondary lymphoid organs during development and in immune
responses. Loss of one or more of these signals likely leads to the
lack of immunologically competent compartments and eventual
regression of PP in Sharpincpdm mutant mice.
Sharpin is conserved among several species, including mice and
humans [38]. Such evolutionary conservation suggests a biological
advantage. Results of this and other studies suggest that
SHARPIN has essential roles in secondary lymphoid organ
development, maturation of B cells and subsequent immunoglob-
ulin production, and control of inflammation. At least some of the
developmental abnormalities observed in Sharpincpdm mutant mice
in the present study appear to be caused by the absence of
SHARPIN in stromal cells, because the compartmentalization of
PP stromal cells is independent of lymphocyte entry [3].
Furthermore, irradiation of juvenile Sharpincpdm mutant mice and
transplantation with bone marrow from healthy donors at a time
when PP are present did not prevent complete regression of PP by
8 weeks of age.
Despite a lack of normal organization, lymphocytes were
recruited into PP anlagen in neonatal mutant mice, indicating
that SHARPIN is essential for the organization and maintenance,
but not the initial development of PP.
Methods
Mice
All experiments involving mice (breeding, genotyping, bone
marrow transplantation, and euthanasia) followed procedures
approved by The Jackson Laboratory Animal Care and Use
Committee under ACUC approvals 07005 and LDS 02–03.
Evaluation of PP Development in Juvenile Mice
Mice used for IFA, immunohistochemistry, and WMI evalua-
tions were F2 and F3 offspring from a cross between Sharpincpdm
PP in Sharpin Deficient Mice
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mutant males and wildtype females of a congenic strain (C.CAST-
(D15Mit156-D15Mit2)/Sun), created for fine mapping of the
Sharpin gene [39,40]. Mice carrying C57BL/KaLawRij-Shar-
pincpdm/RijSunJ alleles at markers flanking the Sharpin region were
identified as mutants. Mice carrying CAST/EiJ alleles, or
heterozygotes, were identified as controls. At least 3 mice per
group were examined for each time point. Although no gross effect
on the phenotype was observed in the mapping cross, to verify that
the phenomenon of PP regression was not attributable to
background genetics of the congenic mapping cross, we examined
sections of the small intestine of C57BL/KaLawRij-Sharpincpdm/
RijSunJ mice at 4 to 7 weeks of age. Results were similar to those
seen in mice from the congenic mapping cross (data not shown).
WMI was performed as previously described with minor
modifications [3,41], using antibodies to ICAM1 (biotinylated,
Pharmingen, 3E2) or B220 (biotinylated, Pharmingen C363.16A).
Briefly, tissues collected at necropsy were immediately fixed in 4%
paraformaldehyde on ice. After 30 minutes, tissues were trans-
ferred into 4% glycine on ice for 30 minutes, then gradually
dehydrated in methanol (MeOH). Blocking was done in 30%
H2O2 in MeOH for 30 minutes, followed by blocking in PBS with
2% dry milk powder and 0.1% Triton-X 100 (PBMST) twice for 1
hour at RT. Biotinylated primary antibody was applied at 2 ug/
mL in PBMST overnight at 4C. After 5 washes in PBMST at 4C,
antibodies were detected using ABC kit (Vectastain Elite, Vector
Labs) at a 1:20 dilution in PBS, for 2 hours at 4C. After 5 washes
in PBMST at 4C, and a final wash in PBST at RT,
diaminobenzidine solution was applied at 250 mg/mL (with
0.05% CoCl2 in some assays) until a color change was observed,
followed by copious washing in PBST. Tissues were gradually
dehydrated in MeOH and examined and photographed using an
Olympus SZX12 dissecting microscope and Olympus DP70
digital camera. Counts of ICAM1+ patches were analyzed for
significance by Student’s t-test and Welch’s t-test.
For histologic evaluation of cross-sections, Swiss rolls of small
intestine collected at necropsy were prepared using a modification
of methods previously described [42]. Paraffin-embedded, Fekete’s
acid alcohol formalin fixed tissues were sectioned at 5 mm and
stained with H&E. For immunofluorescence, a 5-cm segment of
small intestine proximal to the cecum in mice .2 weeks of age, or
Swiss rolls of the small intestine in younger mice, and spleens were
prepared in Optimal Cutting Temperature (OCT, 4583, Sakura,
Torrance CA, USA) compound. The small intestine was removed
at necropsy into PBS on ice, then infused with a mixture of OCT
diluted with 5% sucrose in PBS prior to embedding in OCT and
freezing on dry ice. Blocks were stored at 280C until use,
sectioned at 8 mm and collected on Superfrost Plus glass slides
(Fisher, Rockville, IL, USA). Slides were fixed in acetone at 220C
for 10 minutes and air dried at room temperature for 15 minutes
before washing in PBS, and then placed in an incubation/
humidity chamber. Tissue was incubated with hamster anti-mouse
CD3e (clone 500A2, Pharmingen, NJ, USA) and rat anti-mouse
CD45RB (protein tyrosine phosphatase, receptor type, C, isoform
B; clone 16A, Pharmingen) with 3% FBS 2 hours at room
temperature. Slides were washed in PBS and incubated with
secondary antibody (AlexaFluor 488 goat anti-rat IgG, AlexaFluor
546 goat anti-hamster IgG, Molecular Probes, Invitrogen,
Carlsbad, CA, USA) in PBS and then counterstained with 49,6-
Diamidino-2-phenylindole, dialactate (DAPI; D9564, Sigma, St.
Louis, MO, USA). Slides were washed in PBS, cover slipped with
Fluoromount mounting medium (F4680, Sigma), and examined
and photographed using a Leica DMRXE microscope and
DFC300FX camera or Leica SP5 AOBS confocal microscope.
Bone Marrow Transplantation
Donor mice for bone marrow transplantation were healthy
adult homozygous C57BL/6-Tg(UBC-GFP)30Scha/J females.
Recipient mice were 7-day-old C57BL/KaLawRij-Sharpincpdm/
RijSunJ mutant and control (heterozygous or wildtype; C57BL/
KaLawRij-Sharpincpdm/+ or +/+, respectively) mice. Prior to
transplantation, histocompatibility of donor and recipient mouse
strains was confirmed by maintenance of full thickness dorsal skin
grafts as described elsewhere [43]. Genotypes of recipient mice
were identified via pyrosequencing prior to transplantation.
Femurs and tibias of donor C57BL/6-Tg(UBC-GFP)30Scha/J
mice were surgically removed with sterile forceps and scissors
immediately after euthanasia by CO2 asphyxiation. Bones were
placed in a sterile petri dish containing 5 mL of sterile Hanks
Buffered Saline Solution (HBSS) with 10% FBS. A sterile mortar
and pestle were used to gently crush the bones, and material was
placed in a sterile 50 mL tube and vortexed to release the cells and
allow bone fragments settle to the bottom of the tube. The
supernatant was decanted and poured through a 70 mm mesh
strainer; 10 mL of HBSS was added to the filtered supernatant
and the process was repeated once. Cells were centrifuged, the
supernatant discarded, and red blood cells were lysed with 10 mL
of ammonium chloride lysis buffer (0.15M NH4Cl, 10 mM
KHCO3, 0.1 mM Na2EDTA, pH 7.4) on ice for 10 minutes.
The remaining cells were rinsed twice with HBSS (1 to 5 mL) and
viable cells were counted with a hemacytometer.
Recipient Sharpincpdm (n = 8; 4 females and 4 males) and control
mice (8; 5 females and 3 males) were irradiated at 500 cGy by use
of a Cs irradiator as previously described [44]. Mice were then
injected intraperitoneally with 16107 prepared bone marrow cells
from homozygous GFP+ donors. Mice were observed daily for one
week following engraftment and twice weekly from then on. By 1.5
weeks of age hair loss was evident and at 3 weeks of age mice were
completely hairless. Hair regrowth was detected at 4 weeks of age
and appeared complete by 6 weeks of age.
Two male Sharpincpdm mice died at 8 weeks of age and tissues
were not available for necropsy. Following euthanasia at 7 to 8
weeks of age, complete necropsies were performed in the
remaining 6 Sharpincpdm (4 female and 2 male) and 8 control mice
(5 female and 3 male). Tissues were collected at necropsy and
placed in Fekete’s acid alcohol formalin solution. Slides were
prepared from paraffin-embedded tissues (5 mm thick sections,
including Swiss rolls of the intestine), routinely stained with H&E,
and read by a veterinary pathologist (JPS). The pathologist was not
informed of identification and genotype of the mice at the time of
evaluation; however, skin lesions considered typical of the
Sharpincpdm phenotype were evident to some degree in all mutant
mice, thus evaluation could not be performed in a completely
blinded manner. Engraftment was confirmed in all recipients by
detection of GFP+ cells as previously described [7] in the spleen,
liver, colon, and cecum.
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